Mirae Asset Global Investments
GLUE icon

Mirae Asset Global Investments’s Monte Rosa Therapeutics GLUE Stock Holding History

Mirae Asset Global Investments’s Portfolio GLUE Stock Details GLUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$91.4K Sell
3,778
-199
-5% -$3.76K ﹤0.01% 1252
2026
Q1 		$65.4K Buy
3,977
+813
+26% +$15.5K ﹤0.01% 1246
2025
Q4 		$49.6K Buy
3,164
+776
+32% +$10.5K ﹤0.01% 1397
2025
Q3 		$17.7K Buy
2,388
+12
+0.5% +$64 ﹤0.01% 1509
2025
Q2 		$10.7K Buy
2,376
+320
+16% +$1.43K ﹤0.01% 1482
2025
Q1 		$10.5K Buy
2,056
+9
+0.4% +$55 ﹤0.01% 1469
2024
Q4 		$14.5K Buy
+2,047
New +$15.4K ﹤0.01% 1468
2024
Q2 		– Sell
-11,946
Closed -$80.9K – 1938
2024
Q1 		$80.9K Hold
11,946
– – ﹤0.01% 2391
2023
Q4 		$67.5K Sell
11,946
-1,167
-9% -$4.58K ﹤0.01% 2507
2023
Q3 		$62.8K Buy
13,113
+51
+0.4% +$328 ﹤0.01% 2531
2023
Q2 		$89.5K Sell
13,062
-78
-0.6% -$504 ﹤0.01% 2542
2023
Q1 		$102K Sell
13,140
-31
-0.2% -$216 ﹤0.01% 2442
2022
Q4 		$100K Buy
13,171
+59
+0.4% +$491 ﹤0.01% 2453
2022
Q3 		$108K Buy
+13,112
New +$120K ﹤0.01% 2486

Other funds holding GLUE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $99.1B AUM 124.46% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Mirae Asset Global Investments's GLUE Position: Q2 2026 in Review

Mirae Asset Global Investments reduced its Monte Rosa Therapeutics (GLUE) stake by 5% in Q2 2026, selling an estimated $3.76K and leaving 3,778 shares worth $91.4K. The position accounts for ﹤0.01% of the portfolio, ranked #1252.

Mirae Asset Global Investments first reported a position in GLUE in Q3 2022 and has held it in 14 quarters since. The position peaked at $108K in Q3 2022. 52 funds tracked by Wall St. Rank hold GLUE as of Q2 2026.

  • Mirae Asset Global Investments held 3,778 shares of Monte Rosa Therapeutics worth $91.4K as of Q2 2026.
  • Mirae Asset Global Investments sold 199 Monte Rosa Therapeutics shares in Q2 2026, an estimated $3.76K.
  • Monte Rosa Therapeutics made up ﹤0.01% of Mirae Asset Global Investments's portfolio in Q2 2026, its #1252 holding.
  • Mirae Asset Global Investments first reported a position in Monte Rosa Therapeutics in Q3 2022 and has held it in 14 quarters since.
  • Mirae Asset Global Investments's Monte Rosa Therapeutics position peaked at $108K in Q3 2022.
  • 52 funds tracked by Wall St. Rank held Monte Rosa Therapeutics as of Q2 2026.

Based on Mirae Asset Global Investments's 13F filing for Q2 2026, filed 22 Jul 2026.